文献速递肝病

白细胞介素-33通过5-羟色胺参与的肠-肝轴促进肝再生

Interleukin-33 facilitates liver regeneration through serotonin-involved gut-liver axis.
PubMed 文献 · Hepatology · 2023-04-17

研究在部分肝切除小鼠模型中探讨IL-33对肝再生的作用及机制。IL-33或其受体ST2缺陷导致肝再生延迟,外源性IL-33可恢复IL-33-/-小鼠而非ST2-/-小鼠的肝再生。机制涉及IL-33/ST2诱导肠嗜铬细胞向门脉血释放5-羟色胺,后者通过肝细胞HTR2A/p70S6K促进增殖。

要点

  • IL-33或其受体ST2缺陷延迟小鼠部分肝切除后的肝再生。
  • 外源性IL-33可恢复正常肝再生,但依赖ST2。
  • IL-33/ST2通过肠嗜铬细胞释放5-羟色胺经HTR2A/p70S6K促进肝细胞增殖。

核心结论

  • IL-33在非损伤性肝切除模型中具有促再生作用,机制涉及IL-33/ST2诱导肠嗜铬细胞向门脉血释放5-羟色胺及肝细胞HTR2A/p70S6K激活。

研究设计与样本

  • 在IL-33-/-、ST2-/-和野生型对照小鼠中实施部分肝切除(PHx),并进行体外实验。

主要发现

  • IL-33或ST2缺陷小鼠肝再生延迟;外源性重组鼠IL-33可恢复IL-33-/-小鼠而非ST2-/-小鼠的肝再生。
  • PHx后野生型小鼠门脉血5-羟色胺水平升高,而IL-33-/-或ST2-/-小鼠未升高。
  • 肠嗜铬细胞特异性ST2缺陷重现ST2-/-小鼠肝再生延迟表型。
  • 5-羟色胺受体HTR2A激动剂(±)-2,5-二甲氧基-4-碘安非他命可恢复IL-33-/-和ST2-/-小鼠的肝再生至正常水平。
  • 体外实验显示5-羟色胺/HTR2A诱导的肝细胞增殖依赖p70S6K激活。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Insufficient liver regeneration causes post-hepatectomy liver failure and small-for-size syndrome. Identifying therapeutic targets to enhance hepatic regenerative capacity remains urgent. Recently, increased IL-33 was observed in patients undergoing liver resection and in mice after partial hepatectomy (PHx). The present study aims to investigate the role of IL-33 in liver regeneration after PHx and to elucidate its underlying mechanisms. APPROACH AND RESULTS: We performed PHx in IL-33 -/- , suppression of tumorigenicity 2 (ST2) -/- , and wild-type control mice, and found deficiency of IL-33 or its receptor ST2 delayed liver regeneration. The insufficient liver regeneration could be normalized in IL-33 -/- but not ST2 -/- mice by recombinant murine IL-33 administration. Furthermore, we observed an increased level of serotonin in portal blood from wild-type mice, but not IL-33 -/- or ST2 -/- mice, after PHx. ST2 deficiency specifically in enterochromaffin cells recapitulated the phenotype of delayed liver regeneration observed in ST2 -/- mice. Moreover, the impeded liver regeneration in IL-33 -/- and ST2 -/- mice was restored to normal levels by the treatment with (±)-2,5-dimethoxy-4-iodoamphetamine, which is an agonist of the 5-hydroxytrytamine receptor (HTR)2A. Notably, in vitro experiments demonstrated that serotonin/HTR2A-induced hepatocyte proliferation is dependent on p70S6K activation. CONCLUSIONS: Our study identified that IL-33 is pro-regenerative in a noninjurious model of liver resection. The underlying mechanism involved IL-33/ST2-induced increase of serotonin release from enterochromaffin cells to portal blood and subsequent HTR2A/p70S6K activation in hepatocytes by serotonin. The findings implicate the potential of targeting the IL-33/ST2/serotonin pathway to reduce the risk of post-hepatectomy liver failure and small-for-size syndrome.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Wen Y, Emontzpohl C, Xu L, et al. Interleukin-33 facilitates liver regeneration through serotonin-involved gut-liver axis. Hepatology. 2023. PMID: 36129070. doi:10.1002/hep.32744

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。